Last reviewed · How we verify
NCT07385092: COME ON NOW
Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery
NA trial testing Unblinded continuous vital sign monitoring in Vital Sign Monitoring in 264 participants. Currently enrolling.
1 November 2026
Quick facts
| Lead sponsor | Universitätsklinikum Hamburg-Eppendorf |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 264 |
| Start date | 24 February 2026 |
| Primary completion | 1 November 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Unblinded continuous vital sign monitoring
- Blinded continuous vital sign monitoring
Conditions studied
- Vital Sign Monitoring — all drugs for Vital Sign Monitoring →
- Post Operative Complications — all drugs for Post Operative Complications →
- Non-cardiac Surgery — all drugs for Non-cardiac Surgery →
- RCT — all drugs for RCT →
Sponsor
Universitätsklinikum Hamburg-Eppendorf — full company profile →
Who can join
45 and older, any sex, with Vital Sign Monitoring or Post Operative Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The "COME ON, NOW!" trial is a randomized, single-center trial in patients recovering from non-cardiac surgery on normal wards investigating whether continuous vital sign monitoring - compared to routine spot-checks by nurses - reduces the total duration of abnormal vital signs per hour during the first 48 hours after admission to the normal ward.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07385092
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Unblinded continuous vital sign monitoring
Trials testing the same drug.
- NCT06232876 — Continuous Versus Intermittent Ward Monitoring · NA · not yet recruiting
Other recruiting trials for Vital Sign Monitoring
Currently open trials in the same condition.
- NCT06995742 — Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity · NA · recruiting
- NCT06836947 — The Effect of Two Different Bathing Methods on Vital Signs and Comfort in PICU:Bath Trial · recruiting
Other Universitätsklinikum Hamburg-Eppendorf trials
Trials by the same sponsor.
- NCT07443384 — Complications Associated With Radiofrequency Microneedling in Dermatology: a Delphi Consensus · not yet recruiting
- NCT07009522 — Hamburg Emotion Awareness and Regulation Group Training for Autistic Adolescents (HEART) · EARLY_PHASE1 · not yet recruiting
- NCT07115394 — EEG Measurements to Capture DBS-induced Electric Potentials · recruiting
- NCT06955884 — Patient Experience of Transoral Versus Transnasal Awake Tracheal Intubation · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07385092 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitätsklinikum Hamburg-Eppendorf
- Last refreshed: 2 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07385092.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing